Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy
Yukiko Tanamachi,1 Junji Saruwatari,1 Madoka Noai,1 Ryoko Kamihashi,1 Hiromi Soraoka,1 Yuki Yoshimori,1 Naoki Ogusu,1 Kentaro Oniki,1 Norio Yasui-Furukori,2 Takateru Ishitsu,3,4 Kazuko Nakagawa1,5 1Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto Univ...
Enregistré dans:
Auteurs principaux: | Tanamachi Y, Saruwatari J, Noai M, Kamihashi R, Soraoka H, Yoshimori Y, Ogusu N, Oniki K, Yasui-Furukori N, Ishitsu T, Nakagawa K |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4b73e834b9c94a21aadc13fa8328420a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis.
par: Naoki Ogusu, et autres
Publié: (2014) -
Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
par: Saruwatari J, et autres
Publié: (2013) -
Comparative Efficacy of Levetiracetam for Epilepsy in School-Aged Children with Intellectual Disability and Normal Intelligence
par: Ja Un Moon, et autres
Publié: (2021) -
A novel hemizygous mutation associated with severe intellectual disability and epilepsy: a case report
par: Tong Qiu, et autres
Publié: (2021) -
Epilepsy and intellectual disability linked protein Shrm4 interaction with GABABRs shapes inhibitory neurotransmission
par: Jonathan Zapata, et autres
Publié: (2017)